AXA SA (AXA.DE) Stock Fundamental Analysis
FRA:AXA - Deutsche Boerse Ag - FR0000120628 - Common Stock - Currency: EUR
Overall AXA gets a fundamental rating of 5 out of 10. We evaluated AXA against 38 industry peers in the Insurance industry. AXA has only an average score on both its financial health and profitability. AXA has a decent growth rate and is not valued too expensively. AXA also has an excellent dividend rating. These ratings could make AXA a good candidate for dividend investing.
1. Profitability
1.1 Basic Checks
AXA had positive earnings in the past year.
AXA had a positive operating cash flow in the past year.
Each year in the past 5 years AXA has been profitable.
In the past 5 years AXA always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.18%, AXA is in the better half of the industry, outperforming 60.53% of the companies in the same industry.
The Return On Equity of AXA (15.39%) is better than 68.42% of its industry peers.
AXA has a better Return On Invested Capital (1.33%) than 60.53% of its industry peers.
AXA had an Average Return On Invested Capital over the past 3 years of 1.29%. This is in line with the industry average of 2.30%.
The 3 year average ROIC (1.29%) for AXA is below the current ROIC(1.33%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.18% | ||
| ROE | 15.39% | ||
| ROIC | 1.33% |
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
1.3 Margins
AXA has a Profit Margin (8.80%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of AXA has grown nicely.
Looking at the Operating Margin, with a value of 12.32%, AXA is in line with its industry, outperforming 55.26% of the companies in the same industry.
AXA's Operating Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.32% | ||
| PM (TTM) | 8.8% | ||
| GM | N/A |
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
AXA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
AXA has less shares outstanding than it did 1 year ago.
The number of shares outstanding for AXA has been reduced compared to 5 years ago.
Compared to 1 year ago, AXA has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.35, we must say that AXA is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of AXA (0.35) is better than 84.21% of its industry peers.
The Debt to FCF ratio of AXA is 2.19, which is a good value as it means it would take AXA, 2.19 years of fcf income to pay off all of its debts.
AXA has a better Debt to FCF ratio (2.19) than 76.32% of its industry peers.
AXA has a Debt/Equity ratio of 0.53. This is a neutral value indicating AXA is somewhat dependend on debt financing.
AXA's Debt to Equity ratio of 0.53 is fine compared to the rest of the industry. AXA outperforms 71.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 2.19 | ||
| Altman-Z | 0.35 |
ROIC/WACC0.13
WACC10.47%
2.3 Liquidity
A Current Ratio of 0.87 indicates that AXA may have some problems paying its short term obligations.
AXA's Current ratio of 0.87 is amongst the best of the industry. AXA outperforms 86.84% of its industry peers.
AXA has a Quick Ratio of 0.87. This is a bad value and indicates that AXA is not financially healthy enough and could expect problems in meeting its short term obligations.
AXA has a Quick ratio of 0.87. This is amongst the best in the industry. AXA outperforms 86.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.87 | ||
| Quick Ratio | 0.87 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 12.08% over the past year.
AXA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.09% yearly.
The Revenue has been growing slightly by 4.38% in the past year.
The Revenue has been decreasing by -8.16% on average over the past years.
EPS 1Y (TTM)12.08%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%18.49%
Revenue 1Y (TTM)4.38%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%-6.94%
3.2 Future
The Earnings Per Share is expected to grow by 5.50% on average over the next years.
The Revenue is expected to grow by 7.54% on average over the next years.
EPS Next Y11.56%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
EPS Next 5Y5.5%
Revenue Next Year6.29%
Revenue Next 2Y5.45%
Revenue Next 3Y2.6%
Revenue Next 5Y7.54%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 11.59 indicates a reasonable valuation of AXA.
Based on the Price/Earnings ratio, AXA is valued a bit cheaper than the industry average as 73.68% of the companies are valued more expensively.
AXA is valuated cheaply when we compare the Price/Earnings ratio to 26.32, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 10.39, the valuation of AXA can be described as reasonable.
63.16% of the companies in the same industry are more expensive than AXA, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.19. AXA is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.59 | ||
| Fwd PE | 10.39 |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AXA indicates a somewhat cheap valuation: AXA is cheaper than 65.79% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.68 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of AXA may justify a higher PE ratio.
PEG (NY)1
PEG (5Y)0.64
EPS Next 2Y9.13%
EPS Next 3Y8.44%
5. Dividend
5.1 Amount
AXA has a Yearly Dividend Yield of 5.13%, which is a nice return.
AXA's Dividend Yield is a higher than the industry average which is at 4.47.
AXA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.13% |
5.2 History
The dividend of AXA is nicely growing with an annual growth rate of 8.12%!
Dividend Growth(5Y)8.12%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
AXA pays out 57.97% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of AXA is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP57.97%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
FRA:AXA (6/17/2025, 7:00:00 PM)
41.6
-0.42 (-1%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners33.99%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap92.15B
Analysts81.48
Price Target43.85 (5.41%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.13% |
Yearly Dividend2.02
Dividend Growth(5Y)8.12%
DP57.97%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.24%
PT rev (3m)6.1%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.58%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)6.61%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.59 | ||
| Fwd PE | 10.39 | ||
| P/S | 1.06 | ||
| P/FCF | 7.68 | ||
| P/OCF | 7.39 | ||
| P/B | 1.85 | ||
| P/tB | 3.37 | ||
| EV/EBITDA | N/A |
EPS(TTM)3.59
EY8.63%
EPS(NY)4.01
Fwd EY9.63%
FCF(TTM)5.41
FCFY13.01%
OCF(TTM)5.63
OCFY13.53%
SpS39.43
BVpS22.55
TBVpS12.36
PEG (NY)1
PEG (5Y)0.64
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.18% | ||
| ROE | 15.39% | ||
| ROCE | 1.67% | ||
| ROIC | 1.33% | ||
| ROICexc | 1.37% | ||
| ROICexgc | 1.79% | ||
| OM | 12.32% | ||
| PM (TTM) | 8.8% | ||
| GM | N/A | ||
| FCFM | 13.73% |
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
ROICexc(3y)1.34%
ROICexc(5y)1.16%
ROICexgc(3y)1.75%
ROICexgc(5y)1.48%
ROCE(3y)1.62%
ROCE(5y)1.41%
ROICexcg growth 3Y10.47%
ROICexcg growth 5Y16.55%
ROICexc growth 3Y8.69%
ROICexc growth 5Y14.36%
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 2.19 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 0.54% | ||
| Interest Coverage | 1.72 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 156.03% | ||
| Current Ratio | 0.87 | ||
| Quick Ratio | 0.87 | ||
| Altman-Z | 0.35 |
F-Score7
WACC10.47%
ROIC/WACC0.13
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.46%
Cap/Sales(5y)0.4%
Profit Quality(3y)104.89%
Profit Quality(5y)238.88%
High Growth Momentum
Growth
EPS 1Y (TTM)12.08%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%18.49%
EPS Next Y11.56%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
EPS Next 5Y5.5%
Revenue 1Y (TTM)4.38%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%-6.94%
Revenue Next Year6.29%
Revenue Next 2Y5.45%
Revenue Next 3Y2.6%
Revenue Next 5Y7.54%
EBIT growth 1Y18.59%
EBIT growth 3Y2.9%
EBIT growth 5Y10.41%
EBIT Next Year25.76%
EBIT Next 3Y11.02%
EBIT Next 5YN/A
FCF growth 1Y240.94%
FCF growth 3Y7.74%
FCF growth 5Y9.94%
OCF growth 1Y216.74%
OCF growth 3Y7.85%
OCF growth 5Y9.48%